We are live on !
Find out more
Valentine Capital Asset Management Portfolio holdings
AUM
$89.6M
Turnover
67.98%
1-Year Est. Return
0.84%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
-0.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$89.6M
AUM Growth
-$23.6M
(-21%)
Cap. Flow
-$24.6M
Cap. Flow % of AUM
Cap. Flow %
-27.52%
Top 10 Holdings %
Top 10 Hldgs %
34.59%
Holding
203
New
125
Increased
6
Reduced
57
Closed
13
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.5
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Generac Holdings
GNRC
|
+$3.07M |
| 2 |
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
|
+$2.35M |
| 3 |
Kinder Morgan
KMI
|
+$2.24M |
| 4 |
Direxion Daily Small Cap Bull 3x ETF
TNA
|
+$1.65M |
| 5 |
BGG
Briggs & Stratton Corp.
BGG
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily Financial Bull 3x ETF
FAS
|
+$3.84M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$3.39M |
| 3 |
Ambarella
AMBA
|
+$3.02M |
| 4 |
B&G Foods
BGS
|
+$3.02M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$2.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.27% |
| 2 | Consumer Discretionary | 10.66% |
| 3 | Healthcare | 10.32% |
| 4 | Energy | 9.33% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $4.39M | 4.91% |
28,431
-5,265
| -16% | -$769K |
2013 Q2
10 quarters
|
|
|
2
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$9.9M
| $4.13M | 4.61% |
22,113
+11,826
| +115% | +$2.35M |
2015 Q2
2 quarters
|
|
3
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| $3.93M | 4.39% |
55,991
-10,890
| -16% | -$743K |
2013 Q2
10 quarters
|
|
4
ProShares Ultra NASDAQ Biotechnology
BIB
$107M
| $3.58M | 4% |
50,135
-9,488
| -16% | -$634K |
2013 Q4
8 quarters
|
|
|
5
Generac Holdings
GNRC
$11.4B
| $3.05M | 3.41% |
+102,518
| New | +$3.07M |
2015 Q4
0 quarters
|
|
6
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$29.8M
| $2.63M | 2.94% |
12,819
+3,069
| +31% | +$659K |
2015 Q2
2 quarters
|
|
7
Aberdeen India Fund
IFN
$500M
| $2.48M | 2.77% |
109,103
-24,582
| -18% | -$589K |
2014 Q4
4 quarters
|
|
8
Walt Disney
DIS
$207B
| $2.39M | 2.67% |
22,772
+3,572
| +19% | +$398K |
2013 Q2
10 quarters
|
|
9
AT&T
T
$150B
| $2.2M | 2.46% |
84,687
-15,820
| -16% | -$401K |
2015 Q3
1 quarter
|
|
10
Direxion Daily MSCI India Bull 2X ETF
INDL
$59.6M
| $2.18M | 2.44% |
40,571
-8,205
| -17% | -$455K |
2014 Q4
4 quarters
|
|
11
Omega Healthcare
OHI
$14.6B
| $2.18M | 2.43% |
62,260
-12,315
| -17% | -$425K |
2014 Q4
4 quarters
|
|
12
First Trust NYSE Arca Biotechnology Index Fund
FBT
$3.07B
| $2.06M | 2.3% |
18,270
-3,085
| -14% | -$332K |
2013 Q2
10 quarters
|
|
13
Blackstone
BX
$96.5B
| $1.84M | 2.05% |
62,907
+24,131
| +62% | +$769K |
2015 Q3
1 quarter
|
|
14
Service Properties Trust
SVC
$701M
| $1.6M | 1.79% |
12,255
-2,699
| -18% | -$363K |
2014 Q4
4 quarters
|
|
15
Chevron
CVX
$416B
| $1.53M | 1.71% |
17,030
-3,550
| -17% | -$320K |
2013 Q2
10 quarters
|
|
|
16
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.31B
| $1.53M | 1.71% |
+48,118
| New | +$1.65M |
2015 Q4
0 quarters
|
|
17
Icahn Enterprises
IEP
$3.78B
| $1.53M | 1.7% |
24,896
-5,101
| -17% | -$370K |
2013 Q2
10 quarters
|
|
|
BGG
18
DELISTED
Briggs & Stratton Corp.
BGG
| $1.51M | 1.69% |
+87,226
| New | +$1.63M |
2015 Q4
0 quarters
|
|
19
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $1.48M | 1.66% |
46,150
-8,655
| -16% | -$297K |
2015 Q3
1 quarter
|
|
|
20
Kinder Morgan
KMI
$70.4B
| $1.4M | 1.56% |
+93,940
| New | +$2.24M |
2015 Q4
0 quarters
|
|
21
Wynn Resorts
WYNN
$8.79B
| $1.39M | 1.55% |
+20,063
| New | +$1.34M |
2015 Q4
0 quarters
|
|
22
Under Armour
UAA
$2.15B
| $1.37M | 1.53% |
33,910
-5,960
| -15% | -$272K |
2013 Q2
10 quarters
|
|
23
Target
TGT
$73.9B
| $1.34M | 1.5% |
18,450
-2,900
| -14% | -$216K |
2014 Q4
4 quarters
|
|
24
Salesforce
CRM
$179B
| $1.25M | 1.39% |
15,939
-2,926
| -16% | -$228K |
2015 Q3
1 quarter
|
|
25
Starbucks
SBUX
$125B
| $1.25M | 1.39% |
20,815
-3,831
| -16% | -$233K |
2015 Q3
1 quarter
|
|
Similar funds
TSBJ
TP
SPC
KCA
CCM
ST
Valentine Capital Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, Valentine Capital Asset Management held 203 positions worth $89.6M, down 21% from $113M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Valentine Capital Asset Management withdrew a net $24.6M in Q4 2015, closing 13 positions and reducing 57 holdings. Its most notable exit was Direxion Daily Financial Bull 3x ETF, an estimated $3.84M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Valentine Capital Asset Management opened a new position in Generac Holdings worth $3.05M.
- Valentine Capital Asset Management's largest Q4 2015 buy was Generac Holdings: 102,518 shares worth $3.05M.
- Valentine Capital Asset Management added most to Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 in Q4 2015, an estimated $2.35M increase.
- Valentine Capital Asset Management's biggest Q4 2015 reduction was Jazz Pharmaceuticals, cutting an estimated $3.39M.
- Valentine Capital Asset Management fully exited Direxion Daily Financial Bull 3x ETF in Q4 2015, selling an estimated $3.84M.
- Valentine Capital Asset Management's ten largest holdings make up 35% of its $89.6M portfolio in Q4 2015.
- Valentine Capital Asset Management opened 125 new positions and closed 13 in Q4 2015.
- Valentine Capital Asset Management's portfolio value fell 21% quarter-over-quarter to $89.6M.
Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.